[1]
G. Salazar, MD and C. Motamed, MD, “A remifentanil/ketamine sedation in surgical cancer patients having severe Parkinson’s disease: Two case reports”, J of Opioid Management, vol. 8, no. 2, pp. 133–134, Mar. 2012.